Interestingly, when ASCT2 was knocked down, C118P (50 mg/kg, i.v.)did not exert a clear anti-breast cancer effect on MDA-MB-231 xenografts in nude mice (Figure 8g–i). This evidence concerns the gene SLC1A5 and breast cancer.